Novaliq’s NovaTears® Treatment for Evaporative Dry Eye Disease is Now Available across Australia and New Zealand
June 28, 2018: Cosmo Pharmaceuticals NV
Cosmo Pharmaceuticals Methylene Blue MMX Regulatory Update:
Type A Meeting Request filed to FDA
June 26, 2018: Heidelberg Pharma AG
Heidelberg Pharma Reports Outcome Of Annual General Meeting
June 11, 2018: Molecular Health GmbH
Molecular Health launches MH Mendel for the genetic diagnosis of hereditary diseases
- MH Mendel combines the most relevant information for the diagnosis of hereditary diseases
- MH Mendel helps patients and supports physicians through most modern and comprehensive precision medicine technologies and expertise
- MH Mendel becomes an integral part of IVD registered Molecular Health Guide® 3.0
June 1, 2018: Molecular Health GmbH
Molecular Health launches Molecular Health Guide 3.0, providing improved support for precision medicine
New features for intuitive biomarker classification and improved usability
May 30, 2018: Cosmo Pharmaceuticals NV
Cosmo Pharmaceuticals’ Shareholders approve
all Agenda Items at Annual General Meeting
May 23, 2018: Cosmo Pharmaceuticals NV
Cosmo Pharmaceuticals Receives Complete Response Letter from
the FDA on Methylene Blue MMX NDA
May 23, 2018: Apogenix AG
Apogenix Provides Update on Clinical Development of Asunercept
May 18, 2018: Cosmo Pharmaceuticals NV
FDA accepts new drug application submission for Cosmo
Pharmaceutical’s Rifamycin SV MMX and sets PDUFA date
for November 16, 2018
May 15, 2018: Molecular Health GmbH
Molecular Health to pursue drug repurposing in tuberculosis treatment and perinatal complications
Molecular Health receives grant from Bill & Melinda Gates Foundation